Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Colorectal Neoplasms

  Free Subscription


Articles published in Int J Cancer

Retrieve available abstracts of 88 articles:
HTML format
Text format



Single Articles


    September 2017
  1. HASENOEHRL C, Feuersinger D, Sturm EM, Barnthaler T, et al
    G protein-coupled receptor GPR55 promotes colorectal cancer and has opposing effects to cannabinoid receptor 1.
    Int J Cancer. 2017 Sep 5. doi: 10.1002/ijc.31030.
    PubMed     Text format     Abstract available


    August 2017
  2. MOMEN-HERAVI F, Masugi Y, Qian ZR, Nishihara R, et al
    Tumor Expression of Calcium Sensing Receptor (CASR) and Colorectal Cancer Survival: Results from the Nurses' Health Study and Health Professionals Follow-Up Study.
    Int J Cancer. 2017 Aug 30. doi: 10.1002/ijc.31021.
    PubMed     Text format     Abstract available


  3. EKLOF V, Lofgren-Burstrom A, Zingmark C, Edin S, et al
    Cancer associated faecal microbial markers in colorectal cancer detection.
    Int J Cancer. 2017 Aug 22. doi: 10.1002/ijc.31011.
    PubMed     Text format     Abstract available


  4. CESPEDES FELICIANO EM, Prentice RL, Aragaki AK, Neuhouser ML, et al
    Methodological Considerations for Disentangling a Risk Factor's Influence on Disease Incidence versus Post-Diagnosis Survival: The Example of Obesity and Breast and Colorectal Cancer Mortality in the Women's Health Initiative.
    Int J Cancer. 2017 Aug 18. doi: 10.1002/ijc.30931.
    PubMed     Text format     Abstract available


  5. MEESTER RGS, Doubeni CA, Zauber AG, van Ballegooijen M, et al
    Impact of Adenoma Detection on the Benefit of Faecal Testing versus Colonoscopy for Colorectal Cancer.
    Int J Cancer. 2017 Aug 17. doi: 10.1002/ijc.30933.
    PubMed     Text format     Abstract available


  6. JUBRAN R, Kocsis J, Garam N, Malati E, et al
    Circulating mitochondrial Stress-70 protein/mortalin and cytosolic Hsp70 in blood: Risk indicators in colorectal cancer.
    Int J Cancer. 2017 Aug 9. doi: 10.1002/ijc.30918.
    PubMed     Text format     Abstract available


    July 2017
  7. JIAO W, Leng X, Zhou Q, Wu Y, et al
    Different miR-21-3p isoforms and their different features in colorectal cancer.
    Int J Cancer. 2017 Jul 22. doi: 10.1002/ijc.30902.
    PubMed     Text format     Abstract available


  8. SCHIRRIPA M, Zhang W, Heinemann V, Cao S, et al
    Single nucleotide polymorphisms in the IGF-IRS pathway are associated with outcome in mCRC patients enrolled in the FIRE-3 trial.
    Int J Cancer. 2017;141:383-392.
    PubMed     Text format     Abstract available


  9. BERNTSSON J, Svensson MC, Leandersson K, Nodin B, et al
    The Clinical Impact of Tumour-infiltrating Lymphocytes in Colorectal Cancer Differs by Anatomical Subsite: A Cohort Study.
    Int J Cancer. 2017 Jul 5. doi: 10.1002/ijc.30869.
    PubMed     Text format     Abstract available


  10. KRILAVICIUTE A, Stock C, Brenner H
    International variation in the prevalence of preclinical colorectal cancer: Implications for predictive values of noninvasive screening tests and potential target populations for screening.
    Int J Cancer. 2017 Jul 3. doi: 10.1002/ijc.30867.
    PubMed     Text format     Abstract available


  11. ALAM KJ, Mo JS, Han SH, Park WC, et al
    MicroRNA 375 regulates proliferation and migration of colon cancer cells by suppressing the CTGF-EGFR signaling pathway.
    Int J Cancer. 2017 Jul 3. doi: 10.1002/ijc.30861.
    PubMed     Text format     Abstract available


    June 2017
  12. LAUDATO S, Patil N, Abba ML, Leupold JH, et al
    P53-induced miR-30e-5p inhibits colorectal cancer invasion and metastasis by targeting ITGA6 and ITGB1.
    Int J Cancer. 2017 Jun 28. doi: 10.1002/ijc.30854.
    PubMed     Text format     Abstract available


  13. YANG Y, Wang G, He J, Ren S, et al
    Gender differences in colorectal cancer survival: A Meta-analysis.
    Int J Cancer. 2017 Jun 9. doi: 10.1002/ijc.30827.
    PubMed     Text format     Abstract available


    May 2017
  14. OKAZAKI S, Stintzing S, Sunakawa Y, Cao S, et al
    Predictive value of TLR7 polymorphism for cetuximab-based chemotherapy in patients with metastatic colorectal cancer.
    Int J Cancer. 2017 May 31. doi: 10.1002/ijc.30810.
    PubMed     Text format     Abstract available


  15. WANG N, Lu Y, Khankari NK, Long J, et al
    Evaluation of genetic variants in association with colorectal cancer risk and survival in Asians.
    Int J Cancer. 2017 May 31. doi: 10.1002/ijc.30812.
    PubMed     Text format     Abstract available


  16. CANAVESE M, Ngo DT, Maddern GJ, Hardingham JE, et al
    Biology and therapeutic implications of VEGF-A splice isoforms and single-nucleotide polymorphisms in colorectal cancer.
    Int J Cancer. 2017;140:2183-2191.
    PubMed     Text format     Abstract available


  17. SNAEBJORNSSON P, Jonasson L, Olafsdottir EJ, van Grieken NCT, et al
    Why is colon cancer survival improving by time? A nationwide survival analysis spanning 35 years.
    Int J Cancer. 2017 May 6. doi: 10.1002/ijc.30766.
    PubMed     Text format     Abstract available


  18. BUTT J, Werner S, Willhauck-Fleckenstein M, Michel A, et al
    Serology of Streptococcus gallolyticus subspecies gallolyticus and its association with colorectal cancer and precursors.
    Int J Cancer. 2017 May 6. doi: 10.1002/ijc.30765.
    PubMed     Text format     Abstract available


  19. BRENNER H, Niedermaier T, Chen H
    Strong subsite-specific variation in detecting advanced adenomas by fecal immunochemical testing for hemoglobin.
    Int J Cancer. 2017;140:2015-2022.
    PubMed     Text format     Abstract available


    April 2017
  20. BJERRUM A, Andersen O, Fischer A, Lindebjerg J, et al
    Long term risk of colorectal cancer after negative colonoscopy in a Danish gFOBT screening cohort.
    Int J Cancer. 2017 Apr 30. doi: 10.1002/ijc.30756.
    PubMed     Text format     Abstract available


  21. SENDA NAKAGAWA H, Ito H, Hosono S, Oze I, et al
    Coffee consumption and the risk of colorectal cancer by anatomical subsite in Japan: Results from the HERPACC studies.
    Int J Cancer. 2017 Apr 20. doi: 10.1002/ijc.30746.
    PubMed     Text format     Abstract available


  22. MODEST DP, Stintzing S, Fischer von Weikersthal L, Decker T, et al
    Relation of early tumor shrinkage (ETS) observed in first-line treatment to efficacy parameters of subsequent treatment in FIRE-3 (AIOKRK0306).
    Int J Cancer. 2017;140:1918-1925.
    PubMed     Text format     Abstract available


  23. BEDIN C, Enzo MV, Del Bianco P, Pucciarelli S, et al
    Diagnostic and prognostic role of cell-free DNA testing for colorectal cancer patients.
    Int J Cancer. 2017;140:1888-1898.
    PubMed     Text format     Abstract available


  24. ROMAGUERA D, Gracia-Lavedan E, Molinuevo A, de Batlle J, et al
    Adherence to nutrition-based cancer prevention guidelines and breast, prostate and colorectal cancer risk in the MCC-Spain case-control study.
    Int J Cancer. 2017 Apr 5. doi: 10.1002/ijc.30722.
    PubMed     Text format     Abstract available


  25. JANSEN L, Weberpals J, Kuiper JG, Vissers PA, et al
    Pre- and post-diagnostic beta-blocker use and prognosis after colorectal cancer: Results from a population-based study.
    Int J Cancer. 2017 Apr 1. doi: 10.1002/ijc.30717.
    PubMed     Text format     Abstract available


  26. JAYASEKARA H, MacInnis RJ, Williamson EJ, Hodge AM, et al
    Lifetime alcohol intake is associated with an increased risk of KRAS+ and BRAF-/KRAS- but not BRAF+ colorectal cancer.
    Int J Cancer. 2017;140:1485-1493.
    PubMed     Text format     Abstract available


  27. KUAN FC, Lai CH, Ku HY, Wu CF, et al
    The survival impact of delayed surgery and adjuvant chemotherapy on stage II/III rectal cancer with pathological complete response after neoadjuvant chemoradiation.
    Int J Cancer. 2017;140:1662-1669.
    PubMed     Text format     Abstract available


    March 2017
  28. RODRIGUEZ-BROADBENT H, Law PJ, Sud A, Palin K, et al
    Mendelian randomisation implicates hyperlipidaemia as a risk factor for colorectal cancer.
    Int J Cancer. 2017 Mar 24. doi: 10.1002/ijc.30709.
    PubMed     Text format     Abstract available


  29. ZHU XH, Wang JM, Yang SS, Wang FF, et al
    Down-regulation of DAB2IP promotes colorectal cancer invasion and metastasis by translocating hnRNPK into nucleus to enhance the transcription of MMP2.
    Int J Cancer. 2017 Mar 23. doi: 10.1002/ijc.30701.
    PubMed     Text format     Abstract available


  30. ZHANG L, Li L, Gao G, Wei G, et al
    Elevation of GPRC5A expression in colorectal cancer promotes tumor progression through VNN-1 induced oxidative stress.
    Int J Cancer. 2017 Mar 17. doi: 10.1002/ijc.30698.
    PubMed     Text format     Abstract available


  31. DIETER SM, Giessler KM, Kriegsmann M, Dubash TD, et al
    Patient-derived xenografts of gastrointestinal cancers are susceptible to rapid and delayed B-lymphoproliferation.
    Int J Cancer. 2017;140:1356-1363.
    PubMed     Text format     Abstract available


  32. WILHELMSEN M, Christensen IJ, Rasmussen L, Jorgensen LN, et al
    Detection of colorectal neoplasia: Combination of eight blood-based, cancer-associated protein biomarkers.
    Int J Cancer. 2017;140:1436-1446.
    PubMed     Text format     Abstract available


  33. WANG H, Schmit SL, Haiman CA, Keku TO, et al
    Novel colon cancer susceptibility variants identified from a genome-wide association study in African Americans.
    Int J Cancer. 2017 Mar 13. doi: 10.1002/ijc.30687.
    PubMed     Text format     Abstract available


  34. FIDLER MM, Bray F, Vaccarella S, Soerjomataram I, et al
    Assessing global transitions in human development and colorectal cancer incidence.
    Int J Cancer. 2017 Mar 9. doi: 10.1002/ijc.30686.
    PubMed     Text format     Abstract available


  35. KEUM N, Yuan C, Nishihara R, Zoltick E, et al
    Dietary glycemic and insulin scores and colorectal cancer survival by tumor molecular biomarkers.
    Int J Cancer. 2017 Mar 7. doi: 10.1002/ijc.30683.
    PubMed     Text format     Abstract available


    February 2017
  36. KIRANA C, Ruszkiewicz A, Stubbs RS, Hardingham JE, et al
    Soluble HLA-G is a differential prognostic marker in sequential colorectal cancer disease stages.
    Int J Cancer. 2017 Feb 24. doi: 10.1002/ijc.30667.
    PubMed     Text format     Abstract available


  37. JERZAK KJ, Berry S, Ko YJ, Earle C, et al
    Cetuximab plus Irinotecan versus Panitumumab in Patients with refractory metastatic colorectal cancer in Ontario, Canada.
    Int J Cancer. 2017 Feb 21. doi: 10.1002/ijc.30637.
    PubMed     Text format     Abstract available


  38. ZHANG D, Zhao L, Shen Q, Lv Q, et al
    Down-regulation of KIAA1199/CEMIP by miR-216a suppresses tumor invasion and metastasis in colorectal cancer.
    Int J Cancer. 2017 Feb 18. doi: 10.1002/ijc.30656.
    PubMed     Text format     Abstract available


  39. FASANELLI F, Zugna D, Giraudo MT, Krogh V, et al
    Abdominal adiposity is not a mediator of the protective effect of Mediterranean Diet on colorectal cancer.
    Int J Cancer. 2017 Feb 16. doi: 10.1002/ijc.30653.
    PubMed     Text format     Abstract available


  40. MORRIS SM, Davison J, Carter KT, O'Leary RM, et al
    Transposon mutagenesis identifies candidate genes that cooperate with loss of transforming growth factor-beta signaling in mouse intestinal neoplasms.
    Int J Cancer. 2017;140:853-863.
    PubMed     Text format     Abstract available


  41. CUBIELLA J, Digby J, Rodriguez-Alonso L, Vega P, et al
    The FAST (Faecal Haemoglobin Concentration, Age and Sex Test) Score: Development and external validation of a simple prediction tool for colorectal cancer detection in symptomatic patients.
    Int J Cancer. 2017 Feb 10. doi: 10.1002/ijc.30639.
    PubMed     Text format     Abstract available


    January 2017
  42. HERBST A, Vdovin N, Gacesa S, Philipp A, et al
    Methylated free-circulating HPP1 DNA is an early response marker in patients with metastatic colorectal cancer.
    Int J Cancer. 2017 Jan 25. doi: 10.1002/ijc.30625.
    PubMed     Text format     Abstract available


  43. WALTER V, Jansen L, Knebel P, Chang-Claude J, et al
    Physical activity and survival of colorectal cancer patients: Population-based study from Germany.
    Int J Cancer. 2017 Jan 24. doi: 10.1002/ijc.30619.
    PubMed     Text format     Abstract available


  44. ERTEM FU, Zhang W, Chang K, Mohaiza Dashwood W, et al
    Oncogenic targets Mmp7, S100a9, Nppb and Aldh1a3 from transcriptome profiling of FAP and Pirc adenomas are downregulated in response to tumor suppression by Clotam.
    Int J Cancer. 2017;140:460-468.
    PubMed     Text format     Abstract available


    December 2016
  45. ZAMORA-ROS R, Barupal D, Rothwell JA, Jenab M, et al
    Dietary Flavonoid Intake and Colorectal Cancer Risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) Cohort.
    Int J Cancer. 2016 Dec 22. doi: 10.1002/ijc.30582.
    PubMed     Text format     Abstract available


  46. SEFRIOUI D, Vermeulin T, Blanchard F, Chapusot C, et al
    Copy Number Variations in DCC/18q and ERBB2/17q are Associated with Disease-Free Survival in Microsatellite Stable Colon Cancer.
    Int J Cancer. 2016 Dec 22. doi: 10.1002/ijc.30584.
    PubMed     Text format     Abstract available


  47. MORI K, Toiyama Y, Otake K, Fujikawa H, et al
    Proteomics analysis of differential protein expression identifies Heat shock protein 47 as a predictive marker for lymph node metastasis in patients with colorectal cancer.
    Int J Cancer. 2016 Dec 7. doi: 10.1002/ijc.30557.
    PubMed     Text format     Abstract available


  48. WANG C, Wang Z, Zhou J, Liu S, et al
    TUC.338 promotes invasion and metastasis in colorectal cancer.
    Int J Cancer. 2016 Dec 3. doi: 10.1002/ijc.30542.
    PubMed     Text format     Abstract available


    November 2016
  49. BURON PUST A, Alison R, Blanks R, Pirie K, et al
    Heterogeneity of colorectal cancer risk by tumour characteristics: Large prospective study of UK women.
    Int J Cancer. 2016 Nov 18. doi: 10.1002/ijc.30527.
    PubMed     Text format     Abstract available


  50. ALGARS A, Sundstrom J, Lintunen M, Jokilehto T, et al
    EGFR gene copy number predicts response to anti-EGFR treatment in RAS wild type and RAS/BRAF/PIK3CA wild type metastatic colorectal cancer.
    Int J Cancer. 2016 Nov 5. doi: 10.1002/ijc.30507.
    PubMed     Text format     Abstract available


  51. CHEN Y, Xie Y, Xu L, Zhan S, et al
    Protein content and functional characteristics of serum-purified exosomes from patients with colorectal cancer revealed by quantitative proteomics.
    Int J Cancer. 2016 Nov 3. doi: 10.1002/ijc.30496.
    PubMed     Text format     Abstract available


    October 2016
  52. MOMEN-HERAVI F, Babic A, Tworoger SS, Zhang L, et al
    Periodontal disease, tooth loss, and colorectal cancer risk: Results from the Nurses' Health Study.
    Int J Cancer. 2016 Oct 25. doi: 10.1002/ijc.30486.
    PubMed     Text format     Abstract available


  53. TRABERT B, Eldridge RC, Pfeiffer RM, Shiels MS, et al
    Pre-diagnostic circulating inflammation markers and endometrial cancer risk in the Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial.
    Int J Cancer. 2016 Oct 22. doi: 10.1002/ijc.30478.
    PubMed     Text format     Abstract available


  54. WANG N, Khankari NK, Cai H, Li HL, et al
    Pre-diagnosis Body Mass Index and Waist-Hip Circumference Ratio in Association with Colorectal Cancer Survival.
    Int J Cancer. 2016 Oct 5. doi: 10.1002/ijc.30459.
    PubMed     Text format     Abstract available


    September 2016
  55. SCLAFANI F, Kim TY, Cunningham D, Kim TW, et al
    Dalotuzumab in chemorefractory KRAS exon 2 mutant colorectal cancer: Results from a randomised phase II/III trial.
    Int J Cancer. 2016 Sep 28. doi: 10.1002/ijc.30453.
    PubMed     Text format     Abstract available


  56. SIMONS CC, Schouten LJ, Godschalk RW, van Engeland M, et al
    Energy restriction at young age, genetic variants in the insulin-like growth factor pathway and colorectal cancer risk in the Netherlands Cohort Study.
    Int J Cancer. 2016 Sep 20. doi: 10.1002/ijc.30439.
    PubMed     Text format     Abstract available


  57. MAIERTHALER M, Benner A, Hoffmeister M, Surowy H, et al
    Plasma miR-122 and miR-200 family are prognostic markers in colorectal cancer.
    Int J Cancer. 2016 Sep 15. doi: 10.1002/ijc.30433.
    PubMed     Text format     Abstract available


  58. VAN ERNING FN, Janssen-Heijnen ML, Creemers GJ, Pruijt JF, et al
    Recurrence-free and overall survival among elderly stage III colon cancer patients treated with CAPOX or capecitabine monotherapy.
    Int J Cancer. 2016 Sep 12. doi: 10.1002/ijc.30423.
    PubMed     Text format     Abstract available


  59. PARK C, Kim JI, Hong SN, Jung HM, et al
    A copy number variation in PKD1L2 is associated with colorectal cancer predisposition in Korean population.
    Int J Cancer. 2016 Sep 8. doi: 10.1002/ijc.30421.
    PubMed     Text format     Abstract available


    August 2016
  60. PENG F, Hu D, Lin X, Chen G, et al
    Preoperative metabolic syndrome and prognosis after radical resection for colorectal cancer: The Fujian prospective investigation of cancer (FIESTA) study.
    Int J Cancer. 2016 Aug 25. doi: 10.1002/ijc.30404.
    PubMed     Text format     Abstract available


  61. LI Q, Wei P, Huang B, Xu Y, et al
    MAEL expression links epithelial-mesenchymal transition and stem cell properties in colorectal cancer.
    Int J Cancer. 2016 Aug 18. doi: 10.1002/ijc.30388.
    PubMed     Text format     Abstract available


  62. HASHIMOTO M, Kobayashi T, Tashiro H, Arihiro K, et al
    h-Prune is associated with poor prognosis and epithelial-mesenchymal transition in patients with colorectal liver metastases.
    Int J Cancer. 2016;139:812-23.
    PubMed     Text format     Abstract available


  63. TAKAHASHI Y, Sugai T, Habano W, Ishida K, et al
    Molecular differences in the microsatellite stable phenotype between left-sided and right-sided colorectal cancer.
    Int J Cancer. 2016 Aug 10. doi: 10.1002/ijc.30377.
    PubMed     Text format     Abstract available


    July 2016
  64. JARY M, Lecomte T, Bouche O, Kim S, et al
    Prognostic value of baseline seric Syndecan-1 in initially unresectable metastatic colorectal cancer patients: A simple biological score.
    Int J Cancer. 2016 Jul 29. doi: 10.1002/ijc.30367.
    PubMed     Text format     Abstract available


  65. SALIMZADEH H, Bishehsari F, Amani M, Ansari R, et al
    Advanced Colonic Neoplasia in the First Degree Relatives of Colon Cancer Patients: A Colonoscopy-based Study.
    Int J Cancer. 2016 Jul 29. doi: 10.1002/ijc.30366.
    PubMed     Text format     Abstract available


  66. ZHANG X, Keum N, Wu K, Smith-Warner SA, et al
    Calcium intake and colorectal cancer risk: Results from the Nurses' Health Study and Health Professionals Follow-up Study.
    Int J Cancer. 2016 Jul 28. doi: 10.1002/ijc.30293.
    PubMed     Text format     Abstract available


  67. WEIGL K, Jansen L, Chang-Claude J, Knebel P, et al
    Family history and the risk of colorectal cancer: The importance of patients' history of colonoscopy.
    Int J Cancer. 2016 Jul 26. doi: 10.1002/ijc.30284.
    PubMed     Text format     Abstract available


  68. SOREIDE K
    Resection of asymptomatic primary tumour in unresectable stage IV colorectal cancer: time to move on from propensity matched scores to randomized controlled trials.
    Int J Cancer. 2016 Jul 12. doi: 10.1002/ijc.30244.
    PubMed     Text format    


  69. KAHLERT UD, Mooney SM, Natsumeda M, Steiger HJ, et al
    Targeting Cancer Stem-like Cells in Glioblastoma and Colorectal Cancer through Metabolic Pathways.
    Int J Cancer. 2016 Jul 8. doi: 10.1002/ijc.30259.
    PubMed     Text format     Abstract available


    June 2016
  70. KANTOR ED, Zhang X, Wu K, Signorello LB, et al
    Use of glucosamine and chondroitin supplements in relation to risk of colorectal cancer: Results from the Nurses' Health Study and Health Professionals Follow-up Study.
    Int J Cancer. 2016 Jun 30. doi: 10.1002/ijc.30250.
    PubMed     Text format     Abstract available


  71. LAM-BOER J', Van der Geest LG, Verhoef C, Elferink ME, et al
    Palliative resection of the primary tumor is associated with improved overall survival in incurable stage IV colorectal cancer: A nationwide population-based propensity-score adjusted study in The Netherlands.
    Int J Cancer. 2016 Jun 24. doi: 10.1002/ijc.30240.
    PubMed     Text format     Abstract available


  72. MEULENDIJKS D, Henricks LM, Amstutz U, Froehlich TK, et al
    Rs895819 in MIR27A improves the predictive value of DPYD variants to identify patients at risk of severe fluoropyrimidine-associated toxicity.
    Int J Cancer. 2016;138:2752-61.
    PubMed     Text format     Abstract available


  73. ALLAIRE JM, Roy SA, Ouellet C, Lemieux E, et al
    Bmp signaling in colonic mesenchyme regulates stromal microenvironment and protects from polyposis initiation.
    Int J Cancer. 2016;138:2700-12.
    PubMed     Text format     Abstract available


    May 2016
  74. DUFFY AG, Makarova-Rusher OV, Ulahannan SV, Rahma OE, et al
    Modulation of tumor eIF4E by antisense inhibition: A phase I/II translational clinical trial of ISIS 183750 - an antisense oligonucleotide against eIF4E - in combination with irinotecan in solid tumors and irinotecan-refractory colorectal cancer.
    Int J Cancer. 2016 May 19. doi: 10.1002/ijc.30199.
    PubMed     Text format     Abstract available


    April 2016
  75. VILLACIS RA, Miranda PM, Gomy I, Santos EM, et al
    Contribution of rare germline copy number variations and common susceptibility loci in Lynch syndrome patients negative for mutations in the mismatch repair genes.
    Int J Cancer. 2016;138:1928-35.
    PubMed     Text format     Abstract available


  76. UBILLOS L, Freire T, Berriel E, Chiribao ML, et al
    Trypanosoma cruzi extracts elicit protective immune response against chemically induced colon and mammary cancers.
    Int J Cancer. 2016;138:1719-31.
    PubMed     Text format     Abstract available


  77. EEFSEN RL, Engelholm L, Willemoe GL, Van den Eynden GG, et al
    Microvessel density and endothelial cell proliferation levels in colorectal liver metastases from patients given neo-adjuvant cytotoxic chemotherapy and bevacizumab.
    Int J Cancer. 2016;138:1777-84.
    PubMed     Text format     Abstract available


  78. SAKAI E, Fukuyo M, Ohata K, Matsusaka K, et al
    Genetic and epigenetic aberrations occurring in colorectal tumors associated with serrated pathway.
    Int J Cancer. 2016;138:1634-44.
    PubMed     Text format     Abstract available


    March 2016
  79. LOES IM, Immervoll H, Sorbye H, Angelsen JH, et al
    Impact of KRAS, BRAF, PIK3CA, TP53 status and intra-individual mutation heterogeneity on outcome after liver resection for colorectal cancer metastases.
    Int J Cancer. 2016 Mar 16. doi: 10.1002/ijc.30089.
    PubMed     Text format     Abstract available


  80. KANGWAN N, Kim YJ, Han YM, Jeong M, et al
    Concerted actions of ameliorated colitis, aberrant crypt foci inhibition and 15-hydroxyprostaglandin dehydrogenase induction by sonic hedgehog inhibitor led to prevention of colitis-associated cancer.
    Int J Cancer. 2016;138:1482-93.
    PubMed     Text format     Abstract available


  81. RENAUD F, Mariette C, Vincent A, Wacrenier A, et al
    The serrated neoplasia pathway of colorectal tumors: Identification of MUC5AC hypomethylation as an early marker of polyps with malignant potential.
    Int J Cancer. 2016;138:1472-81.
    PubMed     Text format     Abstract available


  82. IZANO M, Wei EK, Tai C, Swede H, et al
    Chronic inflammation and risk of colorectal and other obesity-related cancers: The health, aging and body composition study.
    Int J Cancer. 2016;138:1118-28.
    PubMed     Text format     Abstract available


  83. DE CUBA EM, Snaebjornsson P, Heideman DA, van Grieken NC, et al
    Prognostic value of BRAF and KRAS mutation status in stage II and III microsatellite instable colon cancers.
    Int J Cancer. 2016;138:1139-45.
    PubMed     Text format     Abstract available


  84. BU Y, Li X, He Y, Huang C, et al
    A phosphomimetic mutant of RelA/p65 at Ser536 induces apoptosis and senescence: An implication for tumor-suppressive role of Ser536 phosphorylation.
    Int J Cancer. 2016;138:1186-98.
    PubMed     Text format     Abstract available


    February 2016
  85. MEGE D, Panicot-Dubois L, Ouaissi M, Robert S, et al
    The origin and concentration of circulating microparticles differ according to cancer type and evolution: A prospective single-center study.
    Int J Cancer. 2016;138:939-48.
    PubMed     Text format     Abstract available


    January 2016
  86. HOBAUS J, Tennakoon S, Heffeter P, Groeschel C, et al
    Impact of CYP24A1 overexpression on growth of colorectal tumour xenografts in mice fed with vitamin D and soy.
    Int J Cancer. 2016;138:440-50.
    PubMed     Text format     Abstract available


  87. CARR PR, Walter V, Brenner H, Hoffmeister M, et al
    Meat subtypes and their association with colorectal cancer: Systematic review and meta-analysis.
    Int J Cancer. 2016;138:293-302.
    PubMed     Text format     Abstract available


    August 2015
  88. AMAYIRI N, Tabori U, Campbell B, Bakry D, et al
    High frequency of mismatch repair deficiency among pediatric high grade gliomas in Jordan.
    Int J Cancer. 2015 Aug 8. doi: 10.1002/ijc.29724.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: